SPRINTer™ eXpress KRAS(G12C) Protein Turnover Biosensor Assay (A549)

The SPRINTer™ eXpress KRAS(G12C) Protein Turnover Biosensor Assay (A549) is used for monitoring drug-induced protein turnover of KRAS. eXpress kits contain all assay materials: cells, reagents, and plates.

Catalog #: 91-1009E015CP0M

$1,789.00$5,989.00


Inquire
Biological Information
Background Information:
The SPRINTer™ eXpress KRAS(G12C) Protein Turnover Biosensor Assay (A549) provides an easy-to-use cell based assay to monitor drug-induced protein turnover of a specific endogenous target. Genome engineering or editing techniques, such as CRISPR/Cas9, are used to introduce a small tag into the endogenous locus of interest. This allows for the quantitation of changes in target protein levels when cells are treated with therapeutic agents such as targeted protein degraders. eXpress kits are a convenient, ready-to-use format which contains all materials needed to run the assay, including single-use vials of cryopreserved cells, cell plating media, detection reagent, and assay plates.
Target Class:
Signaling Pathway
Accession Number:
NP_004976.2; NP_203524.1; P01116
Target Name:
KRAS
Target Aliases:
Kirsten rat sarcoma viral oncogen homolog, KRAS1, K-Ras4B, KRAS proto-oncogene, GTPase
Target Species:
Human
Cell Background:
A549
Usage
Product Type:
eXpress Assay Kits
Application:
Targeted Protein Degradation
Storage Conditions:
Store in vapor phase of liquid nitrogen.
Usage Disclaimer:
Ready-to-use eXpress assay kits are intended for in vitro research purposes only. These kits are not suitable for lot release applications. Refer to the ready-to-use bioassay kit format for potency testing in lot release for biologic therapeutics. These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Assay Information
Assay Type:
Functional
Assay Measures:
Targeted Protein Degradation (TPD)
Detection Method:
Chemiluminescence
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology
Additional Information
Brand:
SPRINTer™

User Manuals & Protocols

70-451 SPRINTer_eXpress_Endogenous_Protein_Turnover_Biosensor_Asssay User_Manual_REV0

View Document

Datasheets

91-1009E015 x Datasheet

View Document